Abstract
Golka and colleagues ([1][1]) critically refer to our observation that NAT2 genotype had no impact on bladder cancer risk ([2][2]). We were able to demonstrate in our case–control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) that occupational exposure to
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
